Advertisement

Diagnostic Immunohistochemistry in Tumor Metastasis

  • Mohib Wadie Morcos
Chapter

Abstract

Immunohistochemistry (IHC) refers to the process of localizing antigens (e.g. proteins) in cells of a tissue section using antibodies that bind specifically to these antigens in bisological tissues Ramos-Vara (Vet Pathol 42:405–426, 2005). Immunohistochemical staining is widely used in the diagnosis of abnormal cells such as those found in cancerous tumors and in metastasis Webster et al. (J Histochem Cytochem 57:753–761, 2009).

Keywords

Epidermal Growth Factor Receptor Gastrointestinal Stromal Tumor Epidermal Growth Factor Receptor Expression Surgical Pathologist Single Cell Clone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bibeau F et al (2006) Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Arch 449:281–287PubMedCrossRefGoogle Scholar
  2. Buchwalow IB, Böcker W (ed) (2010) Antibodies for immunohistochemistry. SpringerLink, p 153Google Scholar
  3. Colcher D, Hand PH, Nuti M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A 78:3199–3203PubMedCrossRefGoogle Scholar
  4. Dällenbach P, Bonnefoi H, Pelte MF, Vlastos G (2006) Yolk sac tumours of the ovary: an update. Eur J Surg Oncol 32:1063–1075PubMedCrossRefGoogle Scholar
  5. Fernando SS, Johnson S, Bate J (1994) Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody. Pathology 26:16–19PubMedCrossRefGoogle Scholar
  6. Gleissner B et al (2005) CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL). Blood 106:4054–4056PubMedCrossRefGoogle Scholar
  7. Gold JS, Dematteo RP (2006) Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 244:176–184PubMedCrossRefGoogle Scholar
  8. Guzman G et al (2005) p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol 18:1498–1503PubMedCrossRefGoogle Scholar
  9. Hans CP et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282PubMedCrossRefGoogle Scholar
  10. Hansen HJ et al (1974) Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol 5:139–147PubMedCrossRefGoogle Scholar
  11. Harari PM (2004) Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer 11:689–708PubMedCrossRefGoogle Scholar
  12. Ikeda S et al (2006) Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. BMC Cancer 6:31Google Scholar
  13. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WDW (1994) Expression of the prostate-specific membrane antigen. Cancer Res 54:1807–1811PubMedGoogle Scholar
  14. Jorgensen JT, Nielsen KV, Ejlertsen B (2007) Pharmacodiagnostics and targeted therapies—a rational approach for individualizing medical anticancer therapy in breast cancer. Oncologist 12:397–405PubMedCrossRefGoogle Scholar
  15. Leader M, Patel J, Makin C, Henry K (1986) An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas. Histopathology 10:1315–1324PubMedCrossRefGoogle Scholar
  16. Martignoni G et al (2004) CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 17:1455–1463PubMedCrossRefGoogle Scholar
  17. Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478PubMedGoogle Scholar
  18. Molino A. et al (1995) Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat 34:221–228PubMedCrossRefGoogle Scholar
  19. Ordóñez NG (2000) Thyroid Transcription Factor-1 is a Marker of Lung and Thyroid Carcinomas. Adv Anat Pathol 7:123–127PubMedCrossRefGoogle Scholar
  20. Ramos-Vara JA (2005) Technical aspects of immunohistochemistry. Vet Pathol 42:405–426PubMedCrossRefGoogle Scholar
  21. Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS (2009) Targeting EGFR resistance networks in head and neck cancer. Cell Signal 21:1255–1268PubMedCrossRefGoogle Scholar
  22. Riddle ND, Quigley BC, Browarsky I, Bui MM (2010) Leiomyosarcoma arising in the pancreatic duct: a case report and review of the current literature. Case Report Med 2010:252–364Google Scholar
  23. Ridolfi RL, Jamehdor MR, Arber JM (2000) HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Mod Pathol 13:866–873PubMedCrossRefGoogle Scholar
  24. Rossi G et al (2004) TTF-1, Cytokeratin 7, 34βE12, and CD56/NCAM Immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 122:884–893PubMedCrossRefGoogle Scholar
  25. Scartozzi M et al (2004) Epidermal Growth Factor Receptor (EGFR) Status in primary colorectal tumors does not correlate with egfr expression in related metastatic sites: implications for treatment with egfr-targeted monoclonal antibodies. J Clin Oncol 22:4772–4778PubMedCrossRefGoogle Scholar
  26. Schlom J (1986) Basic Principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 46:3225–3238PubMedGoogle Scholar
  27. Siebert JD, McClure SP, Banks PM, Gulley ML (1995) Hodgkin’s disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review. Arch Pathol Lab Med 119:474–479PubMedGoogle Scholar
  28. Sigel JE, Hsi ED (2000) Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L. Mod Pathol 13:446–451PubMedCrossRefGoogle Scholar
  29. Sternberger LA, Sternberger NH (1986) The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem 34:599–605PubMedCrossRefGoogle Scholar
  30. Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG (1970) The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18:315–333PubMedCrossRefGoogle Scholar
  31. van Doorn HC, Burger CW, van der Valk P, Bonfrér HMG (2000) Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses. J Clin Pathol 53:201–205PubMedCrossRefGoogle Scholar
  32. Webster JD, Miller MA, Dusold D, Ramos-Vara J (2009) Effects of prolonged formalin fixation on diagnostic immunohistochemistry in domestic animals. J Histochem Cytochem 57:753–761PubMedCrossRefGoogle Scholar
  33. Yilmazer D, Han Ü, Önal B (2007) A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 39:691–698PubMedCrossRefGoogle Scholar
  34. Zubovits J, Buzney E, Yu L, Duncan LM (2004) HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma. Hum Pathol 35:217–223PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Pathology, Centre Hospitalier Affilié Universitaire de Québec, Hôpital l’Enfant-JésusFaculty of Medicine, Laval UniversityQuebecCanada

Personalised recommendations